These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study. Reekie J; Reiss P; Ledergerber B; Sedlacek D; Parczewski M; Gatell J; Katlama C; Fätkenheuer G; Lundgren JD; Mocroft A; HIV Med; 2011 May; 12(5):259-68. PubMed ID: 20812948 [TBL] [Abstract][Full Text] [Related]
10. [Comparative cost-effectiveness analysis between darunavir/ritonavir and other protease inhibitors in treatment-naive human immunodeficiency syndrome type 1-infected patients in Spain]. Smets E; Brogan AJ; Hill A; Adriaenssen I; Sawyer AW; Domingo-Pedrol P; Gostkorzewicz J; Ledesma F Enferm Infecc Microbiol Clin; 2013; 31(7):430-6. PubMed ID: 23260386 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of efavirenz compared with ritonavir-boosted protease-inhibitor-based regimens as initial therapy for patients with plasma HIV-1 RNA above 100,000 copies/ml. Imaz A; Llibre JM; Navarro J; Curto J; Clotet B; Crespo M; Ferrer E; Saumoy M; Tiraboschi JM; Murillo O; Podzamczer D Antivir Ther; 2014; 19(6):569-77. PubMed ID: 24458091 [TBL] [Abstract][Full Text] [Related]
13. [Insulin resistance in HIV-infected patients receiving long-term therapy with efavirenz, lopinavir/ritonavir and atazanavir]. Bernal E; Masiá M; Padilla S; Ramos JM; Martín-Hidalgo A; Gutiérrez F Med Clin (Barc); 2007 Jul; 129(7):252-4. PubMed ID: 17683706 [TBL] [Abstract][Full Text] [Related]
14. Assessing the effectiveness of antiretroviral regimens in cohort studies involving HIV-positive injection drug users. Lima VD; Nosyk B; Wood E; Kozai T; Zhang W; Chan K; Montaner JS AIDS; 2012 Jul; 26(12):1491-500. PubMed ID: 22555161 [TBL] [Abstract][Full Text] [Related]
15. HIV-associated central nervous system diseases in the era of combination antiretroviral therapy. Tan IL; McArthur JC Eur J Neurol; 2011 Mar; 18(3):371-2. PubMed ID: 21159069 [No Abstract] [Full Text] [Related]
16. Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV/AIDS: a systematic review and network meta-analysis. Kanters S; Socias ME; Paton NI; Vitoria M; Doherty M; Ayers D; Popoff E; Chan K; Cooper DA; Wiens MO; Calmy A; Ford N; Nsanzimana S; Mills EJ Lancet HIV; 2017 Oct; 4(10):e433-e441. PubMed ID: 28784426 [TBL] [Abstract][Full Text] [Related]
17. Lipid-lowering effect and efficacy after switching to etravirine in HIV-infected patients with intolerance to suppressive HAART. Casado JL; de Los Santos I; Del Palacio M; García-Fraile L; Pérez-Elías MJ; Sanz J; Moreno S HIV Clin Trials; 2013; 14(1):1-9. PubMed ID: 23372109 [TBL] [Abstract][Full Text] [Related]
18. Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002-2009. Abgrall S; Ingle SM; May MT; Costagliola D; Mercie P; Cavassini M; Reekie J; Samji H; Gill MJ; Crane HM; Tate J; Sterling TR; Antinori A; Reiss P; Saag MS; Mugavero MJ; Phillips A; Manzardo C; Wasmuth JC; Stephan C; Guest JL; Gomez Sirvent JL; Sterne JA; AIDS; 2013 Mar; 27(5):803-13. PubMed ID: 23719350 [TBL] [Abstract][Full Text] [Related]
19. Modern antiretroviral regimens in pregnant women: virologic outcomes and durability. Smith C; Silveira L; Crotteau M; Garth K; Canniff J; Fetters KB; Lazarus S; Capraro S; Weinberg A; AIDS; 2024 Jan; 38(1):21-29. PubMed ID: 37289582 [TBL] [Abstract][Full Text] [Related]
20. Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort. Di Biagio A; Prinapori R; Giannarelli D; Maggiolo F; Di Giambenedetto S; Borghi V; Penco G; Cicconi P; Francisci D; Sterrantino G; Zoncada A; Monno L; Capetti A; Giacometti A; J Antimicrob Chemother; 2013 Jan; 68(1):200-5. PubMed ID: 22915463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]